CHEN ISAN 4
4 · Mirati Therapeutics, Inc. · Filed Jul 17, 2018
Insider Transaction Report
Form 4
CHEN ISAN
Chief Medical & Dev't Officer
Transactions
- Exercise/Conversion
Common Stock
2018-07-16$17.41/sh+275$4,788→ 32,111 total - Exercise/Conversion
Common Stock
2018-07-16$21.51/sh+1,592$34,244→ 34,582 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-07-16−1,592→ 25,908 totalExercise: $21.51Exp: 2025-02-03→ Common Stock (1,592 underlying) - Exercise/Conversion
Employee Stock Option (Right to Buy)
2018-07-16−275→ 5,913 totalExercise: $17.41Exp: 2024-05-20→ Common Stock (275 underlying)
Holdings
- 110(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]Includes 879 shares acquired under the ESPP Purchase on 05/31/18.
- [F2]1/4th of the shares subject to the Option shall vest and become exercisable on the first anniversary of the date of grant, and 1/48th of theshares subject to the Option shall vest each month thereafter until fully vested.